Yu Quan Wei
Directeur/Membre du Conseil chez HINOVA PHARMACEUTICALS INC.
Provenance du réseau au premier degré de Yu Quan Wei
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Kyoto University
42
| College/University | Other Consumer Services | 42 |
| Public Company | Pharmaceuticals: Major | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yu Quan Wei via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Four-Dimensional Data, Inc.
 Four-Dimensional Data, Inc. Information Technology ServicesTechnology Services Part of The Four-Dimensional Group, Inc., Four-Dimensional Data, Inc. provides IT consulting services, especially in the field of Web and email system development. The company is based in Kyoto, Japan. The Japanese company was founded by Akihiro Hatanaka, Genichi Imamura. | Information Technology Services | Chief Executive Officer Founder Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Questetra, Inc.
 Questetra, Inc. Packaged SoftwareTechnology Services Questetra, Inc. develops business process management software. It specializes in the development of process improvement, system development, and communication tools. The firm’s solution enables organizations to develop business process management driven workflow systems through software-as-a-service edition and download edition. Its business activities also include website creation and operation; consulting services and computer software program development; and business investment. The company was founded by Genichi Imamura, Akihiro Hatanaka, Hajime Yahagi, Yoshinori Ehara, and Masato Furukubo on April 1, 2008 and is headquartered in Kyoto, Japan. | Packaged Software | Founder Founder Founder Founder | |
| MITSUI & CO., LTD. | Chemicals: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Remiges Ventures Inc.
 Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Investment Managers | Founder Private Equity Investor | |
| DENA CO., LTD. | Packaged Software | Director of Finance/CFO | |
National Engineering Research Center for Biotechnology
 National Engineering Research Center for Biotechnology BiotechnologyHealth Technology The National Engineering Research Center for Biotechnology provides research and development in the biotechnology sector. | Biotechnology | Director/Board Member | |
| PT CENTURY TEXTILE INDUSTRY TBK | Textiles | Chief Executive Officer | |
Penfabric Sdn. Bhd.
 Penfabric Sdn. Bhd. TextilesProcess Industries Penfabric Sdn. Bhd. produces and markets textile products. It engages in spinning, weaving, dyeing, printing, and finishing operations to produce yarn, grey fabrics, finished fabrics, yarn-dyed fabrics, and grey and dyed yarn for sewing thread. The company was founded in 1973 and is headquartered in Perai, Malaysia. | Textiles | Corporate Officer/Principal | |
| TORAY INDUSTRIES, INC. | Textiles | Corporate Officer/Principal | |
| KOHINOOR ENERGY LIMITED | Alternative Power Generation | Director/Board Member | |
Beijing Tepia Technology Co., Ltd.
 Beijing Tepia Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Tepia Technology Co., Ltd. operates in software and information technology industry. It provides technology and software development and consulting, computer system integration, engineering design and surveys, project management, and irrigation and water resources management services. It also sells computers software hardware, and peripheral products. The company was founded by Bing Yi Liu on November 27, 2000 and is headquartered in Beijing, China. | Packaged Software | Founder | |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| Wuhan University | College/University | Undergraduate Degree | |
| SHENGLONG SPLENDECOR INTERNATIONAL LIMITED | Wholesale Distributors | Director/Board Member | |
Protiviti LLC
 Protiviti LLC Miscellaneous Commercial ServicesCommercial Services Part of Robert Half, Inc., Protiviti LLC is a business consulting firm that provides IT consulting, risk and compliance, digital transformation, and internal audit services. The company is based in Tokyo, Japan. Protiviti also offers a platform for alumni to connect, reminisce, and stay in touch, as well as to introduce, employ, and mentor fellow alumni. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| GNI GROUP LTD. | Biotechnology | Comptroller/Controller/Auditor | |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Biotechnology | Corporate Officer/Principal | |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Cullgen Shanghai, Inc. | Director/Board Member | ||
| GNI-EPS Pharmaceuticals, inc. | Director/Board Member | ||
| Zhejiang A & F University | College/University | Corporate Officer/Principal | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Private Equity Investor | |
| ONO PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Private Equity Investor | |
| Huazhong University of Science & Technology | College/University | Undergraduate Degree | |
| KINGSIGNAL TECHNOLOGY CO., LTD. | Electronic Components | Director/Board Member | |
Hexie Health Insurance Co. Ltd.
 Hexie Health Insurance Co. Ltd. Life/Health InsuranceFinance Hexie Health Insurance Co., Ltd. engages in the provision of health insurance services. The Company was founded on January 12, 2006 and is headquartered in Chengdu, China. | Life/Health Insurance | Director/Board Member | |
| BAOSHENG MEDIA GROUP HOLDINGS LIMITED | Advertising/Marketing Services | Director/Board Member | |
Shiliu Investment Group Ltd.
 Shiliu Investment Group Ltd. Real Estate DevelopmentFinance Shiliu Investment Group Ltd. is a holding company. Through its subsidiaries it engages in property development. It also offers property investment and construction services. The company was founded by Wei Cui and Chun Hua Sang on February 18, 2021 and is headquartered in Beijing, China. | Real Estate Development | Director/Board Member | |
| Tsinghua University School of Economics & Management | College/University | Corporate Officer/Principal | |
| OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD | Electrical Products | Director/Board Member | |
| Zhejiang University | College/University | Graduate Degree | |
Ono Pharma USA, Inc.
 Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | Internet Software/Services | Private Equity Investor | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of Tsukuba | College/University | Doctorate Degree | |
| McGill University | College/University | Masters Business Admin | |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Ono Venture Investment, Inc.
 Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| Nankai University | College/University | Undergraduate Degree | |
| Xi'an Jiaotong University | College/University | Undergraduate Degree | |
| ITOCHU CORPORATION | Food Distributors | Corporate Officer/Principal | |
| Graduate School of Arts & Sciences (Tokyo) | College/University | Doctorate Degree | |
| NextGeM, Inc. | Founder | ||
| PT ASAHIMAS FLAT GLASS TBK | Industrial Specialties | Corporate Officer/Principal | |
| SCINEX CORPORATION | Commercial Printing/Forms | Director/Board Member | |
| Waseda University | College/University | Corporate Officer/Principal | |
| OMNI-PLUS SYSTEM LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
ITOCHU Plastics Pte Ltd.
 ITOCHU Plastics Pte Ltd. Miscellaneous ManufacturingProducer Manufacturing Part of ITOCHU Corp., ITOCHU Plastics Pte Ltd. is a Singaporean company that manufactures plastic products. The company is based in Singapore, Singapore. | Miscellaneous Manufacturing | President |
Statistiques
Internationale
| Chine | 19 |
| Japon | 16 |
| Etats-Unis | 9 |
| Indonésie | 3 |
| Singapour | 3 |
Sectorielle
| Consumer Services | 12 |
| Health Technology | 11 |
| Technology Services | 6 |
| Process Industries | 6 |
| Finance | 6 |
Opérationnelle
| Director/Board Member | 84 |
| Independent Dir/Board Member | 38 |
| Corporate Officer/Principal | 38 |
| Undergraduate Degree | 28 |
| Graduate Degree | 22 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ting Jie Lü | 23 |
| Ruo Yu Chen | 11 |
| Zuo Hao Hu | 11 |
| Shunichiro Matsumoto | 10 |
| Jing Kang Shen | 9 |
| Makoto Haruta | 9 |
| Yuan Wei Chen | 8 |
| Shinya Ikeda | 7 |
| Gen Xie | 6 |
| Kanako Hamasaki | 5 |
| Inaba Taro | 5 |
| Li Shui Song | 5 |
| Katsuya Okajima | 4 |
| Ling Fei Ma | 4 |
| Genichi Imamura | 4 |
- Bourse
- Insiders
- Yu Quan Wei
- Connexions Sociétés
